chrisvoncsefalvay/vaers-outcomes huggingface dataset:
olfactory results of covid vaccine post injection have heightened acrid odors; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NASAL ODOUR (non-serious), outcome "unknown", described as "olfactory results of covid vaccine post injection have heightened acrid odors". Relevant laboratory tests and procedures are available in the appropriate section. The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
contracted COVID 5 days ago; contracted COVID 5 days ago; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 78-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and in Aug2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Aug2023, outcome "unknown" and all described as "contracted COVID 5 days ago". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: states her husband contracted COVID 5 days ago and he is still testing positive on the 5th day. Therapeutic measures were taken as a result of drug ineffective, covid-19. Patient received 2 shot series and then 2 boosters with the last Pfizer COVID-19 booster sometime last Aug2022. He was also on blood thinners which is why he couldn't take Paxlovid. He is currently taking Lagevrio for COVID-19 illness and it has significantly reduced effects of COVID.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Information ahs been received from a nurse practitioner concerning a female who on 08-JAN-2008 was vaccinated in the left arm with the third dose of Gardasil. There was no illness reported that the time of vaccination. It was reported on 11-JAN-2008, that on an unspecified date, the patient developed a rash on her left arm after receiving her third dose of Gardasil. The rash extended from the injection site downward to the elbow and upward to the shoulder. The patient was examined in the office and prescribed Benadryl. No laboratory/diagnostic tests were performed. It was reported that on 11-JAN-2008, that the symptoms resolved after the patient started Benadryl but returned when the Benadryl was discontinued. No further information is available.
The patient reports no adverse events.  The vaccine expired on 3/18/22 per Moderna and the info has been sent to them for a stability test
Information has been received from a physician, for the Pregnancy Registry for Gardasil concerning a female (demographics not provided) who on an unspecified date was vaccinated with her first dose of Gardasil (Lot# not reported).  There was no concomitant medication.  The patient reported to the physician that she found out she was pregnant (method of confirmation and date of the confirmation of the pregnancy were not provided) after she received her first dose of Gardasil.  On an unspecified date the patient reported to the physician that she was about 6 weeks pregnant.  Actual date of her last menstrual period was not reported.  It was reported that the patient sought unspecified medical treatment.  No additional information was provided.  Follow up information received from the physician's office stated that the patient terminated her pregnancy on 31-OCT-2007.  Additional details regarding the elective termination were not provided.  Upon internal review, the elective termination was consider an other medical event.  No further information is available.
This spontaneous report was received from a registered nurse, refers to an unknown number of patients, of an unknown age and gender. Medical history and concurrent conditions were not reported. The register nurse informed that on an unknown date, the patients were vaccinated with ROTATEQ oral (strength, dosage, lot# and expiration date were not reported). That had been improperly stored. No adverse effects were reported. This is one of several cases received from the same reporter. Additional information is not expected because the physician refused to be contacted.
Reaction unknown-vaccine for PREVNAR 13 give SQ instead of IM-tried contacting patient and left message-have not heard back. I called manufacturer...no need to revaccinate but may cause mild site reaction.
It was scary for a while, and he felt awful; Hot fevers; wet the bed in sweat; Shaking; Chills; muscles, arms, legs, and back were hurting; muscles, arms, legs, and back were hurting; muscles, arms, legs, and back were hurting; he was was so sick.; This is a spontaneous report received from a contactable consumer (patient himself). A 65-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot number and expiry date was not reported), via an unspecified route of administration on 22Mar2021 as dose 1, single for COVID-19 immunisation. Medical history included COVID-19 on 13Dec2020. The patient's concomitant medications were not reported. The patient previously took Bamlanivimab infusion of antibodies on 21Dec2020. Patient stated that, he could not receive the COVID vaccine for at least 90 days after this infusion. He received the first COVID vaccine 91 days later on 22Mar2021. He is supposed to have the second dose next Tuesday. After the first vaccine, he was so sick (illness). Early the next morning (23Mar2021) he thought he was going to die. On 23Mar2021, patient stated that he had experienced hot fevers, wet the bed in sweat, shaking, chills, his muscles, arms, legs, and back were hurting terribly. It was scary for a while, and he felt awful the entire next day. He also stated that, the following day he felt better. The outcome of all the events was unknown.   Information about lot/batch number has been requested. Follow-up attempts are completed. No further information is expected.
Patient came in 10/3/12 with swollen, tight red (L) upper arm area with raised skin temperature at area. PAC prescribed SEPTRA susp. and children's ibuprofen.
Around Dec 11, 2006 service member began experiencing an unsteady gait and unsteadiness. His symptoms progressed over the next 2 days to including worsening gait. By Mid day on 13 Dec he noted that he had double vision, worse with distance and no diplopia with reading and slurred speech. He was evaluated and admitted on 12/13/06. He was given fluids and oxygen, with no treatment overnight. By the next morning, his speech had returned to normal, but his diplopia and imbalance was still present. He was given 2 days if IV steroids and noted improvement of all his symptoms. He was discharged on 18 December. He continues to have visual symptoms. He experienced a headache on 26 Dec which was over his right eye and extended to the back of his head, he had not experienced a headache prior and has not experienced a significant headache since. No problems swallowing, weakness, or numbness. No fever during symptoms. Denies cough, chest pain, dyspnea, bowel/bladder dysfunction. No previous history of double vision, dysarthria, episodes of vision loss, weakness or numbness of any body part. See clinical summary.  Pt. reported to ER with c/o 3 day hx of vertigo, unsteady gait, horizontal diplopia, and hazy vision.  He was also noted to have slurred speech. Opthalmic exam 12/14/2006 showed motility as significantly abnormal with complete deficit of the adduction of the left medial rectus.  Good function of all ocular muscles except on the right gaze there was complete absence of the function of the right medial rectus. On the complete left gaze there was a slight deficit  on the right medial rectus. Impression:  Left medial longitudinal folliculus lesion resulting in left internuclear opthalmoplegia.  The lesion causing this is in the left brainstem ventral to the medial longitudinal folliculus in the region between the 3rd and 4th cranial nerve nuclei.  The most common cause is probably multiple sclerosis in his age group, however he may have a longitudinal folliculitis defect.  Neurology consult 12/15/2006 PE WNL except Extra-occular movements demonstrate a Right Internuclear Opthalmoplegia. Impression: R/O MS. R/O peripheral vestibulopathy.  R/O  brain stem tumor or cerebral aneurysm. 03/27/2007 Updated records received.  Pt. reports new symptom of right eye dimness, and the colors not as crisp as his left eye. Assessment:  Initially reported as Optic Neuritis, then Strabismus Non-paralytic Esotropia.
Started with a fever of 101.7.  Fever continued for 2 days, along with headache, muscle aches, and severe fatigue.
Face and neck swelled up, faster heartbeat, a day later severe bloating, gas,  stomach cramps,  stomach cramps lasted several days
2 minutes after IM injection of FLUZONE, Lot U2828AA, patient developed swelling 3 x 3 cm site of injection, intense pruritis, extending shoulder to elbow and increased ASMAY, decreased PEFN.  Treated Benadryl, steroids, cool compress, proventil inhaler.
Pain in arm lasting a week now. Patient describes as a "toothache" in arm. Saw doctor on 11-10-13. Dr thinks it is a pinched nerve or bursitis - not due to flu shot. Patient feels she has limited range of motion now.
8/12/2021 - Received and Email about testing COVID + on 8/8/21.  Called today. They stated that husband had symptoms starting on 8/5/21.  S/S started on 8/8/21.  They both tested on 8/8/21 and both tested positive.
Within 20 minutes of receiving the vaccine, I was experiencing extreme shortness of breath,  my entire body hurt and I was dizzy to the point that I could not stand up without holding onto something. Since the injection, I have felt nauseous everyday, I cannot concentrate,  I become fatigued just standing up. It's been almost six weeks since the injection & I still do not feel right. I fall asleep whenever I sit down and I've fallen asleep while driving.
Pain in her shoulder; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Pain in her shoulder) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced ARTHRALGIA (Pain in her shoulder). At the time of the report, ARTHRALGIA (Pain in her shoulder) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Feb-2021 and was forwarded to Moderna on 09-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Pain in her shoulder) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced ARTHRALGIA (Pain in her shoulder). At the time of the report, ARTHRALGIA (Pain in her shoulder) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided.
Arm was sore for several days at injection site, had severely dry mouth for 4-5 days, continuously thirsty. For 2 days, starting 6/1/21-6/3/21 woke up & room was spinning, dizzy spells. No treatment, for dizzy spells had to just close my eyes & wait at least 45 min for it to go away.
Sore arm immediately after injection. Started getting very achy during the night. Could barely move by the next morning. Severe aches, headache and chills. Have been flat on my back in bed for the last day and a half. Have taken ADVIL only.
Baby had 3h of inconsolable, hyperintense totally uncharacteristic crying last Dtap vaccine. Dr advised that this is generally considered a contraindication to Pertussis.
On 01/05 mom noticed a bump on his thigh that looked like an "insect bite". On 01/06 mom noticed a black center in the middle of the rash. On 01/07 the rash spread 1 cm in diameter on his thigh and she came to the urgent care and was prescribed Mupirocin and Clindamycin which has improved the rash. She states he received the varicella vaccination on 12/26 and the rash is in the same spot on his left thigh. Follow up at our clinic on 01/10/2020. Patient with circumferential erythematous healing abrasion on left anterior mid-thigh with tenderness on palpation.
This spontaneous report was received from a registered nurse and refers to a patient of unknown age. No pertinent medical history, concurrent conditions or concomitant medications were reported. On 22-MAY-2015, the patient was vaccinated with improperly stored PNEUMOVAX23 lot # J011045 with an expiration date of 15-MAY-2015 (expired vaccine administered). The reporter stated that the PNEUMOVAX23 did not have any previous temperature excursions. No adverse symptoms reported. The outcome of the events were unknown. Additional information has been requested.
no taste; COVID-19; Feelings of weakness; very sick; headache; muscle aches; unable to eat; fever; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ASTHENIA (Feelings of weakness), MALAISE (very sick), HEADACHE (headache), MYALGIA (muscle aches) and FEEDING DISORDER (unable to eat) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included OMEPRAZOLE for Acid reflux (esophageal), HYDROCHLOROTHIAZIDE for Hypertension, VITAMIN D [VITAMIN D NOS], VITAMIN C and ZINC for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced ASTHENIA (Feelings of weakness), MALAISE (very sick), HEADACHE (headache), MYALGIA (muscle aches), FEEDING DISORDER (unable to eat) and PYREXIA (fever). On 26-Feb-2021, the patient experienced AGEUSIA (no taste) and COVID-19 (COVID-19). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, ASTHENIA (Feelings of weakness), MALAISE (very sick), HEADACHE (headache), MYALGIA (muscle aches), FEEDING DISORDER (unable to eat), PYREXIA (fever), AGEUSIA (no taste) and COVID-19 (COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Feb-2021, Body temperature increased: borderline (Borderline) 100.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reports that he went to the hospital on 26-FEB-2021 and was positive for COVID virus. Patient remains in quarantine and symptoms are still present.
2 weeks after 1st dose: dizziness, nausea, body aches, headaches, generally feel awful. Lasted for around 2 weeks.  2 weeks after 2nd dose dizziness, nausea, body aches, headaches, feel awful. Continues.
Was in office 3/11, had 12 m shots and developed little fever, then a couple days ago (3/19/2015) started to develop a red bump where VARIVAX vaccine was given, 3/21/2015 also has cold symptoms and a bad cough also-was evaluated in office found to have left thigh mid lateral region with 4 x 1.6 cm diam area of erythema, sl induration, tender to palpation, no fluctuance, no streaking erythema-found to have sterile abscess after vaccine-plan to monitor closely, refer to surgery for eval if increases. Followed up on 3/24/2015 and abscess is getting smaller and less red.
REACTION STARTED BETWEEN 10:15-10:30A, ALMOST IMMEDIATELY AFTER RECEIVING VACCINE. PATIENT HAS NUMBNESS AND TINGLING UP HER ARM WHICH EXTENDED UP TO HER FACE. EMTS WERE CALLED TO FACILITY TO EVALUATE PATIENT. PATIENT WAS CLEARED BY EMT AND ALLOWED TO DRIVE HOME.
Pt recvd Engerix-B & pt was stuck w/ a needle & subsequently was tested for anti-hep B surface titers; & it was determined that pt had no immunity;
Ringing in the ear.  I used to have a very mild ringing in the ear before the vaccine. Like a 1 out of 10 now it?s more like a 4 or 5 on a so scale of 1-10.
COVID (19) was in the building; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 ("COVID (19) was in the building") in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Concomitant products included Unknown for an unknown indication.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 ("COVID (19) was in the building"). At the time of the report, COVID-19 ("COVID (19) was in the building") outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Sender's Comments: A patient of unknown age reported that the she leaves in government housing and the Moderna COVID-19 vaccine series was given to the residents that live at the government housing building.  The patient stated that recently "COVID (19) was in the building". No additional details provided. It is unclear if the patient had COVID 19. The case will be reassessed once additional information is provided.
patient got COVID after their 2 doses; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (patient got COVID after their 2 doses) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (patient got COVID after their 2 doses). At the time of the report, COVID-19 (patient got COVID after their 2 doses) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided. No treatment medication information provided.  The pharmacist asked whether the patient could still receive the booster dose even after contracting COVID disease.  Company Comment: This spontaneous case concerns a patient, of unknown age and gender, with no medical history reported, who experienced the unexpected, non-serious AESI of COVID-19 after administration of the second dose of the Moderna mRNA-1273 vaccine. The start date of the event was not provided. No further details were provided. The outcome of the event was unknown at the time of the report. The benefit-risk relationship of the Moderna mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2022-511612 (Patient Link).; Sender's Comments: This spontaneous case concerns a patient, of unknown age and gender, with no medical history reported, who experienced the unexpected, non-serious AESI of COVID-19 after administration of the second dose of the Moderna mRNA-1273 vaccine. The start date of the event was not provided. No further details were provided. The outcome of the event was unknown at the time of the report. The benefit-risk relationship of the Moderna mRNA-1273 vaccine is not affected by this report.
Onset of fever approx. 101 F in the PM on 3-20-07, small red area noted at injection site. 3-21-07 AM, injection site shows increased redness. 12:45p.m. on 3-21-07. Mother reports area raised and warm to touch, worsened over time. Approximately 1cm growth reported PM on 3-21-07. Dx: Cellulitis Rx: Keflex.
Patient presented here yesterday with lower abdominal pain and was found to have UTI he was discharged on Bactrim after he apparently refused admission, CT at that time showed bilateral perinephric stranding concerning for pyelonephritis Presented back today with dizziness, hypertension, and unable to urinate In the ED, BMP showed significant elevation in creatinine from 1.0 to 2.58, patient was noted to be hypotensive requiring transient norepinephrine with bolus of normal saline x3 (total of 3L) Lactic acid was 1.9 Patient was started on meropenem based on previous sensitivity Continue maintenance IV fluids Blood cultures pending
She got her vaccine, she didn't have a reaction right off the bat.  The next day it started in the afternoon about 2:00 PM she started getting a runny nose.  She kept blowing her nose and thought she was coming down with a cold.  Then she figured it must be a reaction from the vaccine.  That's when she was sitting down watching TV, got up and had pains in her legs, ankles and calves very legs to the point that she could not walk.  She sat right back down again and started rubbing her legs, and decided to walk around.  She kept walking around and walking around her house and sat down afterwards and kept rubbing it, and after a few hours it got a little bit better.  The next day she did not feel good, felt weak, did not feel right.  Then she read the pamphlet that she got and it scared her.    She called her doctor and she informed her to call us and report it.  Her doctor did not give her anything or tell her anything she needed to do.    She had all the COVID shots and did well with those other than a runny nose and a sore throat.    She has been feeling weak, having bad headaches which she does not have.  She is very tired and not feeling like doing her grocery shopping like she normally does.  She is a very active person and makes a list every day to do things, and is not feeling her self yet to do those things.
This spontaneous report as received from a healthcare worker refers to unspecified number of patients of unknown age and gender. The patients' pertinent medical history, drug reactions/allergies and concomitant medications were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of PEDVAXHIB (dose and route were not reported, lot # K011077 with expiration date: 30-MAR-2017, lot # L012837 with expiration date: 11-MAR-2018). No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.